Alliance Global Partners initiated coverage on shares of Curaleaf (OTCMKTS:CURLF) in a report issued on Tuesday, Briefing.com Automated Import reports. The firm issued a buy rating on the stock.
Other analysts have also recently issued reports about the stock. MKM Partners upgraded shares of Curaleaf from a sell rating to a neutral rating in a research note on Wednesday, November 6th. Needham & Company LLC reaffirmed a buy rating and set a $7.25 target price on shares of Curaleaf in a report on Monday, December 23rd. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Curaleaf currently has an average rating of Buy and an average price target of $7.96.
Shares of CURLF stock opened at $6.33 on Tuesday. The firm’s 50 day moving average is $6.58 and its 200 day moving average is $6.41. Curaleaf has a 12 month low of $4.51 and a 12 month high of $11.73.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles.
Recommended Story: How can you know how many shares are floating?
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.